Akut mieloid leukémia (AML): vizsgálatok itt: Kína
226 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaIFN-α in Relapse Prevention.
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 100
- Run by
- Peking University People's Hospital
See details and how to joinNCT07449286 - 2. fázisTaking peopleVenetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
- Where
- Shanghai
- Életkor
- 18 év to 55 év
- People
- 56
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06483906 - 1. fázisNot yet taking people in KínaA Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07441980 - 1/2. fázisTaking peopleBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
- Where
- Beijing
- Életkor
- 8 év to 85 év
- People
- 85
- Run by
- Essen Biotech
See details and how to joinNCT07410494 - No phaseTaking peopleNational Longitudinal Cohort of Hematological Diseases
- Where
- Tianjin
- People
- 2300
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT04645199 - 2. fázisTaking peopleAlternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
- Where
- Beijing, Hangzhou, Nanchang, Shenzhen, Suzhou
- Életkor
- 18 év and over
- People
- 25
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07172204 - 2. fázisTaking peopleGilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
- Where
- Hangzhou
- Életkor
- 18 év to 59 év
- People
- 25
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07259707 - 1. fázisTaking peopleRomiplostim N01 for Platelet Recovery After Haploidentical HSCT
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 130
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07321626 - 1/2. fázisNot yet taking people in KínaClinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Xuzhou
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Xuzhou Medical University
See details and how to joinNCT07370064 - 1. fázisTaking peopleA Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
- Where
- Nanchang, Tianjin, Wuhan
- Életkor
- 18 év to 75 év
- People
- 45
- Run by
- Cullgen (Shanghai),Inc
See details and how to joinNCT07347171 - No phaseNot yet taking people in KínaSafety and Efficacy of CLL1 CAR-T Followed by Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Wuhan
- Életkor
- 18 év to 78 év
- People
- 18
- Run by
- Donghua Zhang
See details and how to joinNCT07342244 - No phaseTaking peopleUsing Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML
- Where
- Beijing
- Életkor
- Up to 18 év
- People
- 283
- Run by
- Peking University People's Hospital
See details and how to joinNCT06452732 - No phaseTaking peopleSafety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation
- Where
- Tianjing
- Életkor
- 18 év and over
- People
- 36
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07297576 - 2. fázisTaking peopleCAV Regimen for R/R AML
- Where
- Suzhou
- Életkor
- 16 év to 70 év
- People
- 68
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05657639 - 2. fázisTaking peoplePost-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML
- Where
- Harbin, Shijiazhuang, Tianjin
- Életkor
- 18 év to 75 év
- People
- 134
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07304232 - 1/2. fázisTaking peopleSupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
- Where
- Tianjin
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07153068 - 1. fázisTaking peopleClinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07263906 - 3. fázisTaking peopleA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
- Where
- Hangzhou, Tianjin
- Életkor
- 18 év and over
- People
- 486 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06389292 · EU 2024-516436-10-00 - 2. fázisTaking peopleVenetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 92
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05566054 - 2. fázisTaking peopleComparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia
- Where
- Suzhou
- Életkor
- 18 év and over
- People
- 172
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06532552 - No phaseTaking peopleClinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Donghua Zhang
See details and how to joinNCT07237230 - 1. fázisNot yet taking people in KínaA Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 24
- Run by
- MEI HENG
See details and how to joinNCT07233018 - 2. fázisTaking peopleRandomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
- Where
- Dongguan, Foshan, Guangzhou, Haikou, Shenzhen, Zhanjiang, Zhuhai
- Életkor
- 18 év and over
- People
- 240
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06451861 - No phaseTaking peopleHigh-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
- Where
- Xining
- People
- 1000
- Run by
- Yigeng Cao,MD,PhD
See details and how to joinNCT07205523 - 1. fázisTaking peopleCLL-1 CAR-NK Cells for Relapsed/Refractory AML
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06307054